Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000653275 | SCV000775154 | benign | 3-methylglutaconic aciduria, type VIIB | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001532180 | SCV001747617 | likely benign | not provided | 2021-03-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001532180 | SCV001881533 | benign | not provided | 2020-06-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002534195 | SCV003703060 | likely benign | Inborn genetic diseases | 2021-10-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV001532180 | SCV005212086 | likely benign | not provided | criteria provided, single submitter | not provided |